Selected research
Industry Research
Duck Vaccines Industry Research Report 2026
Market perspective
The global Duck Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Duck Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Duck Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Duck Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Duck Vaccines include CAHIC, Zoetis, Merck Animal Health, Yebio, Vaksindo, Ringpu Biology, Harbin Veterinary Research Institute, FATRO and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Duck Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Duck Vaccines Market by Company
CAHIC
Zoetis
Merck Animal Health
Yebio
Vaksindo
Ringpu Biology
Harbin Veterinary Research Institute
FATRO
Elanco
CEVA
CAVAC
Boehringer Ingelheim
Duck Vaccines Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Duck Vaccines Segment by Application
Avian Influenza Vaccine
Newcastle Disease Vaccine
Other
Duck Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Duck Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Duck Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Duck Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Duck Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Attenuated Live Vaccines
- Killed Vaccines
Applications
- Avian Influenza Vaccine
- Newcastle Disease Vaccine
- Other
Companies covered
- CAHIC
- Zoetis
- Merck Animal Health
- Yebio
- Vaksindo
- Ringpu Biology
- Harbin Veterinary Research Institute
- FATRO
- Elanco
- CEVA
- CAVAC
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Duck Vaccines Market Size (2021-2032)
- 2.2.2 Global Duck Vaccines Sales (2021-2032)
- 2.2.3 Global Duck Vaccines Market Average Price (2021-2032)
- 2.3 Duck Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Attenuated Live Vaccines
- 2.3.3 Killed Vaccines
- 2.4 Duck Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Avian Influenza Vaccine
- 2.4.3 Newcastle Disease Vaccine
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Duck Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Duck Vaccines Sales (m units) of Manufacturers (2021-2026)
- 3.3 Global Duck Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Duck Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Duck Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Duck Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Duck Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Duck Vaccines, Established Date
- 3.9 Global Duck Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CAHIC
- 4.1.1 CAHIC Company Information
- 4.1.2 CAHIC Business Overview
- 4.1.3 CAHIC Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CAHIC Duck Vaccines Product Portfolio
- 4.1.5 CAHIC Recent Developments
- 4.2 Zoetis
- 4.2.1 Zoetis Company Information
- 4.2.2 Zoetis Business Overview
- 4.2.3 Zoetis Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zoetis Duck Vaccines Product Portfolio
- 4.2.5 Zoetis Recent Developments
- 4.3 Merck Animal Health
- 4.3.1 Merck Animal Health Company Information
- 4.3.2 Merck Animal Health Business Overview
- 4.3.3 Merck Animal Health Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Animal Health Duck Vaccines Product Portfolio
- 4.3.5 Merck Animal Health Recent Developments
- 4.4 Yebio
- 4.4.1 Yebio Company Information
- 4.4.2 Yebio Business Overview
- 4.4.3 Yebio Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yebio Duck Vaccines Product Portfolio
- 4.4.5 Yebio Recent Developments
- 4.5 Vaksindo
- 4.5.1 Vaksindo Company Information
- 4.5.2 Vaksindo Business Overview
- 4.5.3 Vaksindo Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vaksindo Duck Vaccines Product Portfolio
- 4.5.5 Vaksindo Recent Developments
- 4.6 Ringpu Biology
- 4.6.1 Ringpu Biology Company Information
- 4.6.2 Ringpu Biology Business Overview
- 4.6.3 Ringpu Biology Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ringpu Biology Duck Vaccines Product Portfolio
- 4.6.5 Ringpu Biology Recent Developments
- 4.7 Harbin Veterinary Research Institute
- 4.7.1 Harbin Veterinary Research Institute Company Information
- 4.7.2 Harbin Veterinary Research Institute Business Overview
- 4.7.3 Harbin Veterinary Research Institute Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Harbin Veterinary Research Institute Duck Vaccines Product Portfolio
- 4.7.5 Harbin Veterinary Research Institute Recent Developments
- 4.8 FATRO
- 4.8.1 FATRO Company Information
- 4.8.2 FATRO Business Overview
- 4.8.3 FATRO Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 FATRO Duck Vaccines Product Portfolio
- 4.8.5 FATRO Recent Developments
- 4.9 Elanco
- 4.9.1 Elanco Company Information
- 4.9.2 Elanco Business Overview
- 4.9.3 Elanco Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Elanco Duck Vaccines Product Portfolio
- 4.9.5 Elanco Recent Developments
- 4.10 CEVA
- 4.10.1 CEVA Company Information
- 4.10.2 CEVA Business Overview
- 4.10.3 CEVA Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CEVA Duck Vaccines Product Portfolio
- 4.10.5 CEVA Recent Developments
- 4.11 CAVAC
- 4.11.1 CAVAC Company Information
- 4.11.2 CAVAC Business Overview
- 4.11.3 CAVAC Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CAVAC Duck Vaccines Product Portfolio
- 4.11.5 CAVAC Recent Developments
- 4.12 Boehringer Ingelheim
- 4.12.1 Boehringer Ingelheim Company Information
- 4.12.2 Boehringer Ingelheim Business Overview
- 4.12.3 Boehringer Ingelheim Duck Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Boehringer Ingelheim Duck Vaccines Product Portfolio
- 4.12.5 Boehringer Ingelheim Recent Developments
5 Global Duck Vaccines Market Scenario by Region
- 5.1 Global Duck Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Duck Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Duck Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Duck Vaccines Sales by Region: 2027-2032
- 5.3 Global Duck Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Duck Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Duck Vaccines Revenue by Region: 2027-2032
- 5.4 North America Duck Vaccines Market Facts & Figures by Country
- 5.4.1 North America Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Duck Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Duck Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Duck Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Duck Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Duck Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Duck Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Duck Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Duck Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Duck Vaccines Market Facts & Figures by Country
- 5.7.1 South America Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Duck Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Duck Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Duck Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Duck Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Duck Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Duck Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Duck Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Duck Vaccines Sales by Type (2021-2032) & (m units)
- 6.1.2 Global Duck Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Duck Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Duck Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Duck Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Duck Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Duck Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Duck Vaccines Sales by Application (2021-2032) & (m units)
- 7.1.2 Global Duck Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Duck Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Duck Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Duck Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Duck Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Duck Vaccines Value Chain Analysis
- 8.1.1 Duck Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Duck Vaccines Production Mode & Process
- 8.2 Duck Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Duck Vaccines Distributors
- 8.2.3 Duck Vaccines Customers
9 Global Duck Vaccines Analyzing Market Dynamics
- 9.1 Duck Vaccines Industry Trends
- 9.2 Duck Vaccines Industry Drivers
- 9.3 Duck Vaccines Industry Opportunities and Challenges
- 9.4 Duck Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst